Pictet Asset Management
PFE icon

Pictet Asset Management’s Pfizer PFE Stock Holding History

Pictet Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.9M Buy
2,900,775
+187,392
+7% +$4.9M 0.07% 273
2026
Q1 		$76.2M Sell
2,713,383
-38,136
-1% -$1.02M 0.08% 247
2025
Q4 		$68.5M Sell
2,751,519
-178,941
-6% -$4.51M 0.07% 274
2025
Q3 		$74.6M Buy
2,930,460
+6,927
+0.2% +$171K 0.07% 254
2025
Q2 		$70.9M Sell
2,923,533
-48,997
-2% -$1.14M 0.07% 252
2025
Q1 		$75.3M Buy
2,972,530
+475,423
+19% +$12.4M 0.08% 239
2024
Q4 		$66.2M Sell
2,497,107
-59,824
-2% -$1.62M 0.07% 258
2024
Q3 		$74M Sell
2,556,931
-11,597
-0.5% -$338K 0.08% 240
2024
Q2 		$71.9M Sell
2,568,528
-102,202
-4% -$2.81M 0.08% 233
2024
Q1 		$74.1M Sell
2,670,730
-154,688
-5% -$4.29M 0.08% 247
2023
Q4 		$81.3M Buy
2,825,418
+160,623
+6% +$4.86M 0.09% 234
2023
Q3 		$88.4M Buy
+2,664,795
New +$94.2M 0.11% 208

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management's PFE Position: Q2 2026 in Review

Pictet Asset Management increased its Pfizer (PFE) stake by 6.9% in Q2 2026, buying an estimated $4.9M and bringing the position to 2,900,775 shares worth $69.9M. The position accounts for 0.07% of the portfolio, ranked #273.

Pictet Asset Management first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $88.4M in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pictet Asset Management held 2,900,775 shares of Pfizer worth $69.9M as of Q2 2026.
  • Pictet Asset Management bought 187,392 Pfizer shares in Q2 2026, an estimated $4.9M.
  • Pfizer made up 0.07% of Pictet Asset Management's portfolio in Q2 2026, its #273 holding.
  • Pictet Asset Management first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Pfizer position peaked at $88.4M in Q3 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.